Immunomodulating Nanomedicine for Cancer Therapy

Zhigang Liu, Wen Jiang, Jutaek Nam, James J. Moon, Betty Y.S. Kim

Research output: Contribution to journalArticlepeer-review

57 Scopus citations


Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)6655-6659
Number of pages5
JournalNano Letters
Issue number11
StatePublished - Nov 14 2018


  • Nanomedicine
  • cancer immunotherapy
  • cancer vaccine
  • drug delivery
  • nanotechnology

ASJC Scopus subject areas

  • Bioengineering
  • General Chemistry
  • General Materials Science
  • Condensed Matter Physics
  • Mechanical Engineering


Dive into the research topics of 'Immunomodulating Nanomedicine for Cancer Therapy'. Together they form a unique fingerprint.

Cite this